Adding Metastasis-Directed Radiation Therapy Boosts Progression-Free Survival in Metastatic Pancreatic Cancer
Imaging Technology
AUGUST 8, 2024
5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. assistant professor of Gastrointestinal Radiation Oncology. “We
Let's personalize your content